News Now

RESDC Supports Legislation Preserving Access to Affordable Drugs

RESDC recently sent local state legislators letters supporting passage of a first-of-its-kind state legislation to prevent “pay-for-delay” pharmaceutical company pricing practices. The California bill seeks to prevent drug manufacturers offering patent settlements to pay generic companies to delay the introduction of lower-price medication to the market. The bill, AB 824, curbs this practice that reduces competition and arbitrarily keeps life-saving medications more expensive. View legislative information about Assembly Bill 824.

California, feds want to narrow retirement gap. They can’t agree on how

Headline: California, feds want to narrow retirement gap. They can’t agree on how
PublicationSan Francisco Chronicle
Article Date: Jun 8, 2019

“Everyone agrees that something should be done to help the roughly half of U.S. private-sector employees who have no access to a retirement plan at work. After a number of Democratic-leaning states took matters into their own hands, Congress is getting close to a national alternative. But there’s a big difference in the two approaches.” Read article…

The text on this page and any links to articles are being provided as a convenience and for informational purposes only. The views expressed by the authors of the articles are theirs alone, and do not reflect the opinions of RESDC, nor do these links constitute an endorsement or an approval by RESDC. RESDC bears no responsibility for the accuracy, legality, or content of external sites or for that of subsequent links. Contact the external site for answers to questions regarding its content.